Table 10.
One-way sensitivity analysis: input parameters
| Items | Minimuma (%) | Maximuma (%) |
|---|---|---|
| Discount rate | −15 | +15 |
| Age at baseline | −15 | +15 |
| Proportion of male | −15 | +15 |
| SMR | −15 | +15 |
| Probability of interruption (due to patient choice, lost to follow up and other reasons) | −15 | +15 |
| Probability of relapse (due to lack of efficacy) | −15 | +15 |
| Probability of switch (due to lack of tolerance) | −15 | +15 |
| Adverse events | −15 | +15 |
| Initiation of a new antipsychotic (except clozapine) without relapse – outpatient | 90.0 | 100.0 |
| Initiation of a new antipsychotics without relapse – outpatient | 0.0 | 20.0 |
| Hospitalisation cost | −15 | +15 |
| Maintenance cost | −15 | +15 |
| Utility scores (health states) | −15 | +15 |
| Utility decrement (adverse events) | −15 | +15 |
SMR standardised mortality rate
aMinimums and maximums based on expert opinions